Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
Fidaxomicine en vancomycine verlagen 'C. difficile'-uitscheiding en contaminatie van de omgeving
aug 2022 | Bacteriële infecties